- Homepage - GRAIL
GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages
- Clinical Studies - GRAIL
We are committed to the utmost scientific rigor and have enrolled over 300,000 participants in a clinical study program to demonstrate broad applicability of our multi-cancer early detection technologies To support and validate our technology, we are partnering with leading community and academic medical centers around the world
- GRAIL to Present New Data on Galleri® and its Methylation Platform at . . .
GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages
- Multi-cancer early detection - GRAIL
Multi-cancer early detection (MCED) testing is a new approach to screening for cancer Adding a blood-based multi-cancer early detection test can help screen for many of the deadliest cancers that don’t have recommended screening today 7,8
- Press Releases - GRAIL
GRAIL and University of Oxford to Present Results From First Prospective Study of Multi-Cancer Early Detection in a Symptomatic Patient Population at 2023 ASCO Annual Meeting
- About Us - GRAIL
GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to screen for many of the deadliest cancer types before symptoms appear
- Our History - GRAIL
The test detected cell-free DNA from cancer present in the mother’s blood In 2016, Illumina spun out a separate entity to focus on researching this incredible discovery, naming it GRAIL because the co-founders believed a simple blood test could be the “holy GRAIL” of cancer detection
- Leadership Team - GRAIL
To pursue a mission like GRAIL’s, it takes all of us—a unified collective of courageous, adaptable, and open-minded big thinkers dedicated to creating a better world
|